Cost-effectiveness evidence on approved cancer drugs in Ireland : the limits of data availability and implications for public accountability
Suaad Almajed, Nora Alotaibi, Sana Zulfiqar, Zahraa Dhuhaibawi, Niall O’Rourke, Richard Gaule, Caoimhe Byrne, Aaron M. Barry, Dylan Keeley, James F. O’Mahony
Year of publication: |
2022
|
---|---|
Authors: | Almajed, Suaad ; Alotaibi, Nora ; Zulfiqar, Sana ; Dhuhaibawi, Zahraa ; O'Rourke, Niall ; Gaule, Richard ; Byrne, Caoimhe ; Barry, Aaron M. ; Keeley, Dylan ; O'Mahony, James F. |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 23.2022, 3, p. 375-431
|
Subject: | Cost-effectiveness | Policy oversight | Resource allocation | Transparency | Irland | Ireland | Krebskrankheit | Cancer | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis |
Saved in:
freely available
Saved in favorites
Similar items by subject
-
Gulliford, Martin C., (2014)
-
Barbier, Michaela Carla, (2021)
-
Slegerova, Lenka, (2020)
- More ...